NCT06929156View on ClinicalTrials.gov

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Type 2 Diabetes Mellitus (T2DM)Overweight or Obese
Interventions
DRUG

BGM0504

Receive a single dose of BGM0504 injection

DRUG

BGM0504

Receive a single dose of BGM0504 injection

DRUG

BGM0504

Receive a single dose of BGM0504 injection

DRUG

BGM0504

Receive a single dose of BGM0504 injection

Trial Locations (1)

650100

RECRUITING

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province), Jinan

All Listed Sponsors
lead

BrightGene Bio-Medical Technology Co., Ltd.

INDUSTRY